138 related articles for article (PubMed ID: 797443)
1. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
Stout DL; Baptist JN; Matney TS; Shaw CR
Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
[TBL] [Abstract][Full Text] [Related]
2. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
Beranek DT; White GL; Heflich RH; Beland FA
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
Kurelec B; Krca S
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
Stout DL; Becker FF
Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
[No Abstract] [Full Text] [Related]
5. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
Schut HA; Thorgeirsson SS
Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
[No Abstract] [Full Text] [Related]
6. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
Jacobs MM; Matney TS; Griffin AC
Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
[TBL] [Abstract][Full Text] [Related]
7. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
Holme JA; Haug LT; Dybing E
Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
Razzouk C; Batardy-Grégoire M; Roberfroid M
Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
[TBL] [Abstract][Full Text] [Related]
9. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
[No Abstract] [Full Text] [Related]
10. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse.
Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS
Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463
[No Abstract] [Full Text] [Related]
11. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
Castro CE; Felkner IC; Yang SP
Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
[No Abstract] [Full Text] [Related]
12. Synergistic effect of diethylstilbestrol on the mutagenicity of 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene in the Salmonella assay system.
Allaben WT; Louie SC; Lazear EJ
Cancer Lett; 1979 Jul; 7(2-3):109-14. PubMed ID: 476604
[TBL] [Abstract][Full Text] [Related]
13. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
Hinson JA; Andrews LS; Gillette JR
Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
[No Abstract] [Full Text] [Related]
14. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
[TBL] [Abstract][Full Text] [Related]
15. Deacetylation to 2-aminofluorene as a major initial reaction in the microsomal metabolism of 2-acetylaminofluorene to mutagenic products in preparations from rabbit lung and liver.
Aune T; Vanderslice RR; Croft JE; Dybing E; Bend JR; Philpot RM
Cancer Res; 1985 Nov; 45(11 Pt 2):5859-66. PubMed ID: 4053056
[TBL] [Abstract][Full Text] [Related]
16. Comparative electrophilicity, mutagenicity, DNA repair induction activity, and carcinogenicity of some N- and O-acyl derivatives of N-hydroxy-2-aminoflourene.
Bartsch H; Malaveille C; Stich HF; Miller EC; Miller JA
Cancer Res; 1977 May; 37(5):1461-7. PubMed ID: 322856
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR.
Wirth PJ; Alewood P; Calder I; Thorgeirsson SS
Carcinogenesis; 1982; 3(2):167-70. PubMed ID: 6896016
[TBL] [Abstract][Full Text] [Related]
18. Influence of disulfiram on mutagenicity of the urinary metabolites of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the Salmonella test system.
El-Torkey NM; Weisburger EK
Mutat Res; 1983 Jul; 118(1-2):1-6. PubMed ID: 6346083
[TBL] [Abstract][Full Text] [Related]
19. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
McGregor D
Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
[TBL] [Abstract][Full Text] [Related]
20. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene.
Robertson IG
Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
